3,644 reports of this reaction
3.3% of all ETONOGESTREL reports
#6 most reported adverse reaction
INCORRECT PRODUCT ADMINISTRATION DURATION is the #6 most commonly reported adverse reaction for ETONOGESTREL, manufactured by Organon LLC. There are 3,644 FDA adverse event reports linking ETONOGESTREL to INCORRECT PRODUCT ADMINISTRATION DURATION. This represents approximately 3.3% of all 110,074 adverse event reports for this drug.
Patients taking ETONOGESTREL who experience incorrect product administration duration should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
INCORRECT PRODUCT ADMINISTRATION DURATION is moderately reported among ETONOGESTREL users, representing a notable but not dominant share of adverse events.
In addition to incorrect product administration duration, the following adverse reactions have been reported for ETONOGESTREL:
The following drugs have also been linked to incorrect product administration duration in FDA adverse event reports:
INCORRECT PRODUCT ADMINISTRATION DURATION has been reported as an adverse event in 3,644 FDA reports for ETONOGESTREL. This does not prove causation, but indicates an association observed in post-market surveillance data.
INCORRECT PRODUCT ADMINISTRATION DURATION accounts for approximately 3.3% of all adverse event reports for ETONOGESTREL, making it a notable side effect.
If you experience incorrect product administration duration while taking ETONOGESTREL, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.